SEROPREVALENCE OF HBsAg AND ANTI-HCV IN GENERAL HEALTHY POPULATION OF SWAT DISTRICT WITH FREQUENCY OF DIFFERENT HCV GENOTYPES

被引:0
|
作者
Ahmad, Aziz [1 ,2 ]
Ahmad, Bilal [1 ,2 ]
Ali, Amjad [1 ,2 ]
Ahmad, Yasir [1 ,2 ]
机构
[1] Saidu Med Coll, Dept Med, Saidu Sharif, Swat, Pakistan
[2] Teaching Hosp, Saidu Sharif, Swat, Pakistan
关键词
HBsAg; anti-HCV; Seroprevalence; Genotypes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The main purpose of this study was to find out the seroprevatence of HBsAg and anti HCV in apparently healthy population of district Swat. The other objective was to find out the different types of genotype prevalent in this part of the country. Methodology: This is a descriptive, observational study which is community based and was conducted by the Hepatology section of Medical Department, Saidu Teaching Hospital, Saidu Sharif from May 2007 to August 2008. Screening camps were held in all the four sectors to which the district was arbitrarily divided. Sera were checked by 3 generation Elisa technique for HBsAg and anti HCV antibody. Positive cases for anti HCV were recalled in batches and the blood samples taken for HCV RNA testing by PCR and Genotyping. Results: Data was available on a total of 4680 healthy men and women. There were 2870 male and 1810 female participants. We found 3871 (82.7%) subjects Negative. One hundred sixty four (3.5%) were positive for HBsAg and 645(13.8%) were positive for anti-HCV antibodies. Only 15 volunteers (0.3%) were infected with both HBV and HCV. Two hundred twenty cases, who were positive for HCV RNA BY PCR testing were checked for genotyping. One hundred nine (49.5%) cases had genotype 3a, 74(33.7%) cases were having genotype 3b, 19 cases (8.7%) had mixed, 10 cases (4.5%) had lb and eight cases(3.6%) were untypeble. Conclusion: In district Swat of NWFP, prevalence of hepatitis B surface antigenmia is 3.5% and anti Hepatitis C antibody is 13.8% with a combined prevalence of 17.3%. Genotype three is the commonest genotype (83%) prevalent in this area and six months combination antiviral therapy can be undertaken without checking for genotype in routine.
引用
收藏
页码:744 / 748
页数:5
相关论文
共 50 条
  • [41] HIGH-FREQUENCY OF HCV VIREMIA IN ANTI-HCV POSITIVE HEMODIALYZED PATIENTS
    POL, S
    ROMEO, R
    ZINS, B
    LEBKIRI, B
    BERTHELOT, P
    BRECHOT, C
    HEPATOLOGY, 1992, 16 (04) : A218 - A218
  • [42] DOES THE HEALTHY CARRIER STATE OF ANTI-HCV EXIST
    BRUNO, S
    ROSSI, S
    VILLA, E
    BATTEZZATI, PM
    PETRONI, ML
    CHIESA, A
    PODDA, M
    HEPATOLOGY, 1993, 18 (04) : A224 - A224
  • [43] SEROPREVALENCE OF ANTI-HCV IN AN URBAN CHILD POPULATION - A PILOT SURVEY IN A DEVELOPING-AREA, CAMEROON
    NGATCHU, T
    STROFFOLINI, T
    RAPICETTA, M
    CHIONNE, P
    LANTUM, D
    CHIARAMONTE, M
    JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1992, 95 (01): : 57 - 61
  • [44] Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups
    Benjelloun, S
    Bahbouhi, B
    Sekkat, S
    Bennani, A
    Hda, N
    Benslimane, A
    RESEARCH IN VIROLOGY, 1996, 147 (04): : 247 - 255
  • [45] HEPATITIS-C VIRUS (HCV) GENOTYPES AND CLINICAL COURSE OF ANTI-HCV POSITIVE CIRRHOSIS
    BENVEGNU, L
    PONTISSO, P
    CAVALLETTO, D
    CHEMELLO, L
    ALBERTI, A
    HEPATOLOGY, 1995, 22 (04) : 945 - 945
  • [46] Seroprevalence of anti-HCV antibodies among blood donors of north India
    Makroo, R. N.
    Walia, Rimpreet Singh
    Chowdhry, Mohit
    Bhatia, Aakanksha
    Hegde, Vikas
    Rosamma, N. L.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2013, 138 : 124 - 127
  • [47] LOW SEROPREVALENCE FOR ANTI-HCV IN AN ENDEMIC AREA FOR A KNOWN FLAVIVIRUS (DENGUE)
    JEFFERS, L
    GEORGE, G
    CHARLES, E
    REDDY, R
    FARLEY, K
    SILVA, M
    LALOS, A
    AVILA, M
    HILL, M
    ROMANO, N
    KUO, G
    BARTHOLOMEW, C
    SCHIFF, E
    HEPATOLOGY, 1991, 14 (04) : A207 - A207
  • [48] Screening of HBsAg and Anti-HCV from Tertiary Care Hospital of Lahore
    Hameed, Aalia
    Izhar, Mateen
    Ali, Akbar
    Fazal-E-Bari
    Ahmed, Irshad
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2016, 10 (02): : 587 - 589
  • [49] Risk management of HBsAg or anti-HCV positive healthcare workers in hospital
    Mele, A
    Ippolito, G
    Craxi, A
    Coppola, RC
    Petrosillo, N
    Piazza, M
    Puro, V
    Rizzetto, M
    Sagliocca, L
    Taliani, G
    Zanetti, A
    Barni, M
    Bianco, E
    Bollero, E
    Cargnel, A
    Cattaneo, M
    Chiaramonte, M
    Conti, E
    D'Amelio, R
    De Stefano, DM
    Di Giulio, S
    Franco, E
    Gallo, G
    Levrero, M
    Mannella, E
    Merli, S
    Milazzo, F
    Moiraghi, A
    Polillo, R
    Prati, D
    Ragni, P
    Sagnelli, E
    Scognamiglio, P
    Sommella, L
    Stroffolini, T
    Terrana, T
    Tosolini, G
    Vitiello, E
    Zanesco, L
    Ziparo, V
    Maffei, C
    Moro, ML
    Satolli, R
    Traversa, G
    DIGESTIVE AND LIVER DISEASE, 2001, 33 (09) : 795 - 802
  • [50] Infection rate and spontaneous serorevertion of anti-HCV during natural course of HCV infection in a general population of central Italy
    Kondili, LA
    Chionne, P
    Costantino, A
    Villano, U
    Pannozzo, F
    Mele, A
    Gianpaoli, S
    Rapicetta, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 116 - 116